LP63637-0

Fondaparinux

Active

Description

Routine testing of Factor Xa inhibitor levels is not recommended because they have such a wide therapeutic index. Testing should only be done in special circumstances. Fondaparinux (brand name Arixtra) is a synthetic pentasaccharide with selective inhibition of activated factor X (Xa), used for prophylaxis and treatment of deep vein thrombosis (DVT). Measurement of fondaparinux anti-Xa activity is performed to monitor fondaparinux levels and potential adverse reactions (e.g. anticoagulant-associated severe bleeding). Fondaparinux is mainly excreted by the kidneys and has a half-life of 15 to 17 hours. Specimen samples are typically collected 3-4 hours after taking the drug. Source: Regenstrief LOINC

Basic Part Properties

Part Name

Fondaparinux

Part Display Name

Fondaparinux

Part Type

Component (Describes the core component or analyte measured)

Created On

2007-05-02

Construct for LOINC Short Name

Fondaparinux

Related Codes

LOINC Terminology Service (API) using HL7^® FHIR^® Get Info

Requests to this service require a free LOINC username and password. Below is a sample of the possible capabilities. See the LOINC Terminology Service documentation for more information.

CodeSystem lookup

https://fhir.loinc.org/CodeSystem/$lookup?system=http://loinc.org&code=LP63637-0

ConceptMap translate

https://fhir.loinc.org/ConceptMap/$translate?system=http://loinc.org&code=LP63637-0

Language Variants Get Info

LOINC Copyright

Copyright © 2025 Regenstrief Institute, Inc. All Rights Reserved. To the extent included herein, the LOINC table and LOINC codes are copyright © Regenstrief Institute, Inc. and the Logical Observation Identifiers Names and Codes (LOINC) Committee. See https://loinc.org/license for the full LOINC copyright and license.